Elizabeth Muchmore

3.1k total citations · 2 hit papers
40 papers, 2.4k citations indexed

About

Elizabeth Muchmore is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, Elizabeth Muchmore has authored 40 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 17 papers in Virology and 10 papers in Infectious Diseases. Recurrent topics in Elizabeth Muchmore's work include HIV Research and Treatment (17 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (8 papers). Elizabeth Muchmore is often cited by papers focused on HIV Research and Treatment (17 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (8 papers). Elizabeth Muchmore collaborates with scholars based in United States, France and Japan. Elizabeth Muchmore's co-authors include Marc Girard, Françoise Barré‐Sinoussi, Hiroaki Okamoto, Shunji Mishiro, David Peterson, Christopher M. Walker, Michael Houghton, Ann L. Erickson, Amy J. Weiner and Hiroshi Yoshizawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

In The Last Decade

Elizabeth Muchmore

40 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

1991 303 citations Marc Girard, Françoise Barré‐Sinoussi et al. Proceedings of the National Academy of Sciences profile →
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.

1995 286 citations Amy J. Weiner, Ann L. Erickson et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Muchmore United States	23	1.3k	1.1k	976	615	463	40	2.4k
Rodney Phillips United Kingdom	19	1.0k 0.8×	1.5k 1.3×	819 0.8×	1.5k 2.4×	360 0.8×	27	2.8k
Cindy Christopherson United States	21	974 0.8×	811 0.7×	1.8k 1.8×	455 0.7×	1.5k 3.2×	29	3.1k
Michelina Nascimbeni United States	21	1.8k 1.4×	1.9k 1.8×	514 0.5×	1.6k 2.6×	383 0.8×	25	3.5k
Marian Major United States	29	2.2k 1.8×	2.8k 2.5×	428 0.4×	559 0.9×	291 0.6×	61	3.4k
Justin R. Bailey United States	33	1.1k 0.9×	1.1k 1.0×	2.2k 2.2×	1.1k 1.8×	1.4k 3.0×	64	3.5k
Agata Budkowska France	25	1.3k 1.0×	1.3k 1.2×	148 0.2×	336 0.5×	200 0.4×	60	2.0k
Simona Urbani Italy	20	1.8k 1.4×	1.8k 1.7×	262 0.3×	1.3k 2.2×	331 0.7×	29	2.8k
Daniélé Primi Italy	25	665 0.5×	526 0.5×	184 0.2×	1.2k 2.0×	368 0.8×	84	2.5k
Alexander W. Tarr United Kingdom	29	2.0k 1.5×	2.4k 2.2×	464 0.5×	311 0.5×	361 0.8×	75	3.3k
Christoph Neumann‐Haefelin Germany	35	1.8k 1.4×	2.3k 2.1×	416 0.4×	1.7k 2.8×	396 0.9×	111	4.0k

Countries citing papers authored by Elizabeth Muchmore

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Muchmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Muchmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Muchmore more than expected).

Fields of papers citing papers by Elizabeth Muchmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Muchmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Muchmore. The network helps show where Elizabeth Muchmore may publish in the future.

Co-authorship network of co-authors of Elizabeth Muchmore

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Muchmore. A scholar is included among the top collaborators of Elizabeth Muchmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Muchmore. Elizabeth Muchmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Girard, Marc, James Mahoney, Qing Wei, et al.. (1998). Genital Infection of Female Chimpanzees with Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 14(15). 1357–1367. 35 indexed citations

Pride, Michael W., Christopher R. Bailey, Elizabeth Muchmore, & Yasmin Thanavala. (1998). Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene®, a hepatitis B vaccine containing pre-S1, pre-S2 and S gene products. Vaccine. 16(6). 543–550. 29 indexed citations

Coëffier, Eliane, Marc Girard, Françoise Barré‐Sinoussi, et al.. (1998). Fine Specificity of Anti-V3 Antibodies Induced in Chimpanzees by HIV Candidate Vaccines. AIDS Research and Human Retroviruses. 14(12). 1023–1034. 3 indexed citations

Huguenel, E D, David E. Cohn, J M Greve, et al.. (1997). Prevention of Rhinovirus Infection in Chimpanzees by Soluble Intercellular Adhesion Molecule-1. American Journal of Respiratory and Critical Care Medicine. 155(4). 1206–1210. 53 indexed citations

Grob, Peter M., Yunzhen Cao, Elizabeth Muchmore, et al.. (1997). Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase. Nature Medicine. 3(6). 665–670. 28 indexed citations

Barré‐Sinoussi, Françoise, Marie‐Claude Georges‐Courbot, Patricia N. Fultz, et al.. (1997). Characterization and Titration of an HIV Type 1 Subtype E Chimpanzee Challenge Stock. AIDS Research and Human Retroviruses. 13(7). 583–591. 7 indexed citations

Girard, Marc, Ling Yue, F Barré-Sinoussi, et al.. (1996). Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain. Journal of Virology. 70(11). 8229–8233. 25 indexed citations

Weiner, Amy J., Ann L. Erickson, Joe Kansopon, et al.. (1995). Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.. Proceedings of the National Academy of Sciences. 92(7). 2755–2759. 286 indexed citations breakdown →

Tabor, Edward, Chu Chieh Hsia, & Elizabeth Muchmore. (1994). Histochemical and immunohistochemical similarities between hepatic tumors in two chimpanzees and man. Journal of Medical Primatology. 23(5). 271–279. 7 indexed citations

10.

Erickson, Ann L., Michael Houghton, Q-L. Choo, et al.. (1993). Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.. The Journal of Immunology. 151(8). 4189–4199. 114 indexed citations

11.

Okamoto, Hiroaki, Masataka Sakamoto, M. Kojima, et al.. (1993). A Structurally Flexible and Antigenically Variable N-Terminal Domain of the Hepatitis C Virus E2/NS1 Protein: Implication for an Escape from Antibody. Virology. 195(1). 297–301. 164 indexed citations

12.

Fultz, Patricia N., Jean‐Claude Gluckman, Elizabeth Muchmore, & Marc Girard. (1992). Transient Increases in Numbers of Infectious Cells in an HIV-infected Chimpanzee Following Immune Stimulation. AIDS Research and Human Retroviruses. 8(2). 313–317. 43 indexed citations

13.

Neurath, A. R., Shibo Jiang, Hanno V.J. Kolbe, et al.. (1991). Antibody Responses of Chimpanzees Immunized with Synthetic Peptides Corresponding to Full-Length V3 Hypervariable Loops of HIV-1 Envelope Glycoproteins. AIDS Research and Human Retroviruses. 7(10). 813–823. 25 indexed citations

14.

Rao, Patricia E., et al.. (1991). OKT3E, AN ANTI-CD3 ANTIBODY THAT DOES NOT ELICIT SIDE EFFECTS OR ANTIIDIOTYPE RESPONSES IN CHIMPANZEES. Transplantation. 52(4). 691–697. 17 indexed citations

15.

Bahraoui, Elmostafa, Micaël Yagello, Jean-Noël Billaud, et al.. (1990). Immunogenicity of the Human Immunodeficiency Virus (HIV) Recombinant nef Gene Product. Mapping of T-Cell and B-Cell Epitopes in Immunized Chimpanzees. AIDS Research and Human Retroviruses. 6(9). 1087–1098. 31 indexed citations

16.

Mishiro, Shunji, Yuji Hoshi, Akira Yoshikawa, et al.. (1990). Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. The Lancet. 336(8728). 1400–1403. 170 indexed citations

17.

Yagello, Micaël, Marc Girard, Marie-Paule Kiény, et al.. (1989). Cell-Mediated Immune Proliferative Responses to HIV-1 of Chimpanzees Vaccinated with Different Vaccinia Recombinant Viruses. AIDS Research and Human Retroviruses. 5(1). 41–50. 23 indexed citations

18.

Muchmore, Elizabeth, Hans Pópper, David Peterson, M. F. Miller, & Harvey M. Lieberman. (1988). Non‐A, Non‐B Hepatitis‐Related Hepatocellular Carcinoma in a Chimpanzee. Journal of Medical Primatology. 17(5). 235–246. 52 indexed citations

19.

Muchmore, Elizabeth. (1987). An Overview of Biohazards Associated With Nonhuman Primates. Journal of Medical Primatology. 16(2). 55–82. 5 indexed citations

20.

Muchmore, Elizabeth. (1973). Clinical Care of Nonhiiman Primates. Journal of Medical Primatology. 2(6). 341–352. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact